Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Antibiotic Resistance in Bacteria, and Infectious Diseases and Tuberculosis.
The TB27 Transcriptomic Model for Predicting Mycobacterium tuberculosis Culture Conversion
Impact of enhanced infection control and antimicrobial stewardship on infections by Clostridioides difficile, vancomycin-resistant enterococci, and third-generation cephalosporin-resistant Enterobacterales: a stepped-wedge cluster intervention study
Accuracy of cobas MTB and MTB-RIF/INH for Detection of Mycobacterium tuberculosis and Drug Resistance.
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland
Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone
Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis—An ESGMYC collaborative study
Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis-An ESGMYC collaborative study.
Nicht tuberkulöse Mykobakteriosen
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution
Therapie bei MDR-, prä-XDR-, XDR-Tuberkulose und Rifampicin-Resistenz oder bei Medikamentenunverträglichkeit gegenüber mindestens Rifampicin
Minimum inhibitory concentrations and sequencing data have to be analysed in more detail to set provisional epidemiological cut-off values for <i>Mycobacterium tuberculosis</i> complex.
Emergence of bedaquiline resistance in a high tuberculosis burden country.
Ancient and recent differences in the intrinsic susceptibility of <i>Mycobacterium tuberculosis</i> complex to pretomanid
Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid.
Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing.
Tuberkulose im Erwachsenenalter
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
Origin and Global Expansion of <i>Mycobacterium tuberculosis</i> Complex Lineage 3.
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.
One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk.
Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients.
Delineating Mycobacterium abscessus population structure and transmission employing high-resolution core genome multilocus sequence typing.
C25-modified rifamycin derivatives with improved activity against <i>Mycobacterium abscessus</i>.
Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region: Action is Needed by all Member States.
The Use of Comparative Genomic Analysis for the Development of Subspecies-Specific PCR Assays for <i>Mycobacterium abscessus</i>.
Sub-Lineage Specific Phenolic Glycolipid Patterns in the <i>Mycobacterium tuberculosis</i> Complex Lineage 1.
Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond.